Recent studies have shown that inhibiting Rac1 activity [26] or knocking down LIMK1 expression [27] abrogated their effects on malignant phenotypes, including increased growth and invasion in gastric cancer cells. This evidence concerns the gene RAC1 and gastric cancer.